01-07-2025 07:40 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Company News
Mankind Pharma Ltd.
Change Company   
BSE Code 543904
ISIN Demat INE634S01028
Book Value 354.72
NSE Code MANKIND
Dividend Yield % 0.00
Market Cap 958686.34
P/E 50.88
EPS 45.65
Face Value 1  
10-Jun-2025 Mankind Pharma informs about allotment of equity ...
05-Jun-2025 Mankind Pharma gets ESG score of 38.98 from ISS E...
05-Jun-2025 Mankind Pharma gains on the BSE
22-May-2025 Mankind Pharma gets nod to incorporate wholly own...
22-May-2025 Mankind Pharma reports 11% fall in Q4 consolidate...
12-May-2025 Mankind Pharma informs about conference call
15-Apr-2025 Mankind Pharma gets nod to incorporate wholly own...
03-Apr-2025 Mankind Pharma informs about compliances certific...
01-Mar-2025 Mankind Pharma informs about disclosure
10-Feb-2025 Mankind Pharma informs about outcome of board mee...
15-Jan-2025 Mankind Pharma informs about update
27-Dec-2024 Mankind Pharma, Innovent Biologics partner to com...
20-Dec-2024 Mankind Pharma informs about updates
15-Nov-2024 Mankind Pharma informs about disclosure
06-Nov-2024 Mankind Pharma informs about newspaper publicati...
Page 1 of 2
Prev || Next
 

Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors

KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’

Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.